![Pieter B. M. W. M. Timmermans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter B. M. W. M. Timmermans
Director Técnico/Científico/I+D en Kosan Biosciences, Inc. .
Cargos activos de Pieter B. M. W. M. Timmermans
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Director Técnico/Científico/I+D | 01/01/2005 | - |
Historial de carrera de Pieter B. M. W. M. Timmermans
Antiguos cargos conocidos de Pieter B. M. W. M. Timmermans.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01/08/2004 | 01/01/2005 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1997 | 01/01/2004 |
University of Amsterdam | Corporate Officer/Principal | - | - |
Formación de Pieter B. M. W. M. Timmermans.
University of Leiden | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Países Bajos | 3 |
Operativa
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AMGEN INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |